AU1608400A - Method of treating arthritis with human parvovirus b19 antigens or antibodies against same - Google Patents
Method of treating arthritis with human parvovirus b19 antigens or antibodies against sameInfo
- Publication number
- AU1608400A AU1608400A AU16084/00A AU1608400A AU1608400A AU 1608400 A AU1608400 A AU 1608400A AU 16084/00 A AU16084/00 A AU 16084/00A AU 1608400 A AU1608400 A AU 1608400A AU 1608400 A AU1608400 A AU 1608400A
- Authority
- AU
- Australia
- Prior art keywords
- antigens
- antibodies against
- treating arthritis
- human parvovirus
- against same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000702617 Human parvovirus B19 Species 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 206010003246 arthritis Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14211—Erythrovirus, e.g. B19 virus
- C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14211—Erythrovirus, e.g. B19 virus
- C12N2750/14234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10784898P | 1998-11-10 | 1998-11-10 | |
US60107848 | 1998-11-10 | ||
PCT/US1999/026150 WO2000027431A1 (en) | 1998-11-10 | 1999-11-04 | Method of treating arthritis with human parvovirus b19 antigens or antibodies against same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1608400A true AU1608400A (en) | 2000-05-29 |
Family
ID=22318804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16084/00A Abandoned AU1608400A (en) | 1998-11-10 | 1999-11-04 | Method of treating arthritis with human parvovirus b19 antigens or antibodies against same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1608400A (en) |
WO (1) | WO2000027431A1 (en) |
-
1999
- 1999-11-04 WO PCT/US1999/026150 patent/WO2000027431A1/en active Application Filing
- 1999-11-04 AU AU16084/00A patent/AU1608400A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000027431A1 (en) | 2000-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1462300A (en) | Human pan-hcv human monoclonal antibodies | |
EP0831880A4 (en) | Antibody and antibody fragments for inhibiting the growth of tumors | |
ZA966240B (en) | Methods for treatment of allergic asthma. | |
PT1818343E (en) | Antibodies against human il-12 | |
AU1559895A (en) | Antisense oligonucleotides specific for stk-1 and method for inhibiting expression of the stk-1 protein | |
AU1704099A (en) | Monoclonal human natural antibodies | |
EP0675534A3 (en) | SOI substrate and method of producing the same. | |
AU7676300A (en) | Human anti-adipocyte monoclonal antibodies and their use | |
AU6407094A (en) | Method of treating tumors with antibodies | |
AU3374699A (en) | Methods of preparing and using electrostatically treated fluids | |
AU1697197A (en) | Immunoconjugate for the treatment of aids | |
AU3444899A (en) | Method for the rapid determination of bacteria | |
AU4393497A (en) | Method for the sterilization of biological materials | |
AU1538497A (en) | Anti-gp46 antibodies and fragments thereof and their use | |
EP0749445A4 (en) | Antibodies which bind the g-csf receptor extracellular domain and methods of treatment | |
EP0977590A4 (en) | Human monoclonal antibodies | |
EP0845712A4 (en) | Pigment composition for liquid toner, method of manufacturing the same and liquid toner manufacturing method | |
NO981822L (en) | Use of the GAX protein for the treatment of cancer | |
HRP970224A2 (en) | TREATMENT OF ASTHMA WITH TNFR-Ig | |
AU2643495A (en) | Assay for pathogenicity of anti-dna antibodies | |
AU1608400A (en) | Method of treating arthritis with human parvovirus b19 antigens or antibodies against same | |
IT1282937B1 (en) | APPARATUS FOR THE TREATMENT OF GLASSES, CUPS AND SIMILAR | |
IL117722A0 (en) | Method for the microbial decontamination of blood platelets | |
ZA969315B (en) | Processes and intermediates for the preparation of ziprasidone. | |
AU1940800A (en) | Combination therapy for the treatment of sepsis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |